Optical Coherence Tomography Angiography Equipment Market Research Report and Outlook by 2028

The optical coherence tomography angiography (OCTA) equipment market is anticipated to grow significantly, reaching an estimated US$ 616.31 million by 2028, up from US$ 388.50 million in 2021. This growth represents a compound annual growth rate (CAGR) of 6.8% from 2021 to 2028. The increasing incidence of various eye disorders, coupled with the availability of affordable diagnostic methods, is driving the expansion of the OCTA equipment market.

According to a report by the World Health Organization (WHO), approximately 2.2 billion individuals worldwide experience some form of vision impairment, whether near or far. Notably, around 1 billion of these cases are preventable through the implementation of advanced technologies that facilitate early detection of eye conditions. This group includes those suffering from moderate to severe distance vision impairment or blindness due to unaddressed refractive errors (88.4 million), cataracts (94 million), glaucoma (7.7 million), corneal opacities (4.2 million), diabetic retinopathy (3.9 million), and trachoma (2 million). Additionally, near vision impairment caused by unaddressed presbyopia affects around 826 million people.

The Optica Publishing Group has highlighted that OCTA has become a crucial instrument for assessing retinal health in adults. Its noninvasive nature allows for the generation of objective biomarkers, which are measurable indicators of a patient's medical condition. This capability leads to earlier and more effective diagnoses of retinal diseases. Furthermore, OCTA is now regarded as a standard practice in adult retinal care, thanks to its ability to detect subclinical diseases and monitor disease progression in many cases of blindness.

Moreover, the rapid approval of OCTA equipment by the Food and Drug Administration (FDA) has further promoted the adoption of this advanced technology. For example, in August 2021, Abbott received FDA clearance for its latest OCT imaging platform, which is powered by the new Ultreon Software. This innovative product provides physicians with a detailed view of coronary blood flow and blockages, aiding in clinical decision-making and optimizing treatment pathways for patients. Such developments are expected to significantly boost the global optical coherence tomography equipment market from 2021 to 2028.

The market for optical coherence tomography angiography equipment has been categorized based on type and end user. In terms of type, the market is divided into handheld and tabletop devices. The tabletop segment is projected to hold a larger share of the market during the period from 2021 to 2028. According to the Association for Research in Vision and Ophthalmology, OCTA has transformed the diagnosis and management of various eye conditions. The Optica Publishing Group also notes that this technique serves as a functional extension of OCT, designed for noninvasive imaging. Consequently, most current angiography systems are tabletop models, which are typically used for imaging compliant and seated patients, yielding satisfactory reproducibility results. These factors contribute to the growth of the OCTA equipment market, particularly for the tabletop segment.

Conversely, the handheld segment is expected to experience a higher CAGR during the same period. This anticipated growth is due to the increasing adoption of handheld devices, which provide high-resolution imaging results. Handheld devices are compact, battery-operated systems that integrate all necessary optical components, processing units, and a lightweight display. Their enhanced portability and supportive technologies have led to widespread acceptance in hospitals and clinics globally. These attributes are crucial for the overall growth of the optical coherence tomography angiography equipment market from 2021 to 2028.

When examining the market by end user, the optical coherence tomography angiography equipment market is segmented into hospitals, clinics, and others. The hospital segment is expected to dominate the market throughout the forecast period. This dominance is primarily due to the rising prevalence of eye disorders, including diabetic retinopathy and glaucoma, which have driven the increased adoption of OCTA technology in hospital settings. The growth of the hospital segment is further supported by collaborations between leading manufacturers and hospitals to enhance their product offerings and services, thereby benefiting the optical coherence tomography angiography equipment market.

Key sources of information for this report include the World Health Organization (WHO), Optical Publishing Group, Association for Research in Vision and Ophthalmology, and the National Institute of Health (NIH).